Neurology News

CHARLOTTE, N.C. — The link between sleep apnea and cardiovascular disease involves multiple pathways and outcomes, Susan Redline, MD, MPH, Peter C. Farrell Professor of Sleep Medicine at Harvard Medical School, said at SLEEP 2022.

Patients treated for stroke at non-urban hospitals in New Zealand experience poorer outcomes and face reduced access to crucial stroke interventions across the entire care spectrum, according to a study published in Neurology.

Inclisiran effectively and safely lowered LDL in patients with hyperlipidemia and prior cerebrovascular disease, according to a pooled analysis of the three ORION trials presented at the National Lipid Association Scientific Sessions.

The FDA has extended its new drug application review of AMX0035, a combination of sodium phenylbutyrate and taurursodiol for the treatment of ALS, Amylyx Pharmaceuticals Inc. announced in a press release.

Renin-angiotensin-aldosterone system inhibitor use in patients with hypertension and intracranial aneurysm was associated with lower risk for aneurysm rupture compared with nonuse, according to research published in Hypertension.

Black and Hispanic medical students and physicians are considerably underrepresented in the United States compared with the national population, according to findings published in JAMA Network Open.

The COVID-19 pandemic was a likely cause for worsened disparities in buprenorphine and naltrexone access for opioid use disorder among minority groups compared with white patients, per a study published in JAMA Network Open.

Pediatric melatonin consumption in the United States has risen more than fivefold since 2012, with related hospitalization increasing as well, according to data published Thursday in MMWR.

High efficacy and acceptability were demonstrated in both on-label and off-label medications for fibromyalgia, reinforcing the value of symptom-based treatment plans, according to a study published in JAMA Network Open.

NEW ORLEANS – A number of new treatments are on the horizon for PTSD, making the future bright for patients with this condition, Charles B. Nemeroff, MD, PhD, said at the American Psychiatric Association annual meeting.